methyllucidone

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Prostatic Neoplasms (Prostate Cancer) 01/01/2018 - "Methyllucidone inhibited STAT3 phosphorylation at tyrosine 705 in a dose- and time dependent manner in DU145 prostate cancer cells and suppressed IL-6-induced STAT3 phosphorylation at Tyr-705 in LNCaP cells. "
2.	Neoplasms (Cancer) 11/15/2005 - "The results suggest that methyllucidone can be a potential anti-cancer agent against H-ras-transformed tumor and will also be a good lead molecule for the development of anti-tumor drug." 11/15/2005 - "Methyllucidone strongly inhibited the growth of human cancer cells and colon tumor xenografted in nude mice. "
3.	Carcinoma (Carcinomatosis) 01/01/2018 - "Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells."

1.	Protein Tyrosine Phosphatases
2.	Tyrosine (L-Tyrosine)